SGK1-dependent upregulation of connective tissue growth factor by angiotensin II

Kidney and Blood Pressure Research

Volumn 31, Issue 2, 2008, Pages 80-86

  Hussain, Azeemudeen ^a   Wyatt, Amanda W ^a   Wang, Kan ^a   Bhandaru, Madhuri ^a   Biswas, Raja ^a   Avram, Diana ^a   Föller, Michael ^a   Rexhepaj, Rexhep ^a   Friedrich, Björn ^a   Ullrich, Susanne ^a   Müller, Gerhard ^b   Kuhl, Dietmar ^c   Risler, Teut ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Connective tissue growth factor; Fibrosis; Human kidney fibroblasts; Serum and glucocorticoid inducible kinase

Indexed keywords

ANGIOTENSIN II; CONNECTIVE TISSUE GROWTH FACTOR; SERUM AND GLUCOCORTICOID REGULATED KINASE 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE TARGETING; HUMAN; HUMAN CELL; LUNG FIBROBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; WILD TYPE;

ANGIOTENSIN II; ANIMALS; CELL LINE; FIBROBLASTS; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; LUNG; MICE; MICE, KNOCKOUT; PROTEIN-SERINE-THREONINE KINASES; UP-REGULATION;

EID: 43049125513     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000119703     Document Type: Article

References (67)

1. Brown RD, Ambler SK, Mitchell MD, Long CS: The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 2005;45:657-687.
2. Opie LH, Sack MN: Enhanced angiotensin II activity in heart failure: reevaluation of the counterregulatory hypothesis of receptor subtypes. Circ Res 2001;88:654-658.
3. Candido R, Jandeleit-Dahm KA, Cao Z, Nesteroff SP, Burns WC, Twigg SM, Dilley RJ, Cooper ME, Allen TJ: Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation 2002;106:246-253.
4. Rasoul S, Carretero OA, Peng H, Cavasin MA, Zhuo J, Sanchez-Mendoza A, Brigstock DR, Rhaleb NE: Antifibrotic effect of Ac-SDKP and angiotensin- converting enzyme inhibition in hypertension. J Hypertens 2004;22:593-603.
5. Struthers AD, MacDonald TM: Review of aldosterone-and angiotensin II-induced target organ damage and prevention. Cardiovasc Res 2004;61:663-670.
6. Touyz RM: Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II. Curr Opin Nephrol Hypertens 2005;14:125-131.
7. Brown NJ, Vaughan DE, Fogo AB: The renin-angiotensin-aldosterone system and fibrinolysis in progressive renal disease. Semin Nephrol 2002;22:399-406.
8. Connolly SB, Sadlier D, Kieran NE, Doran P, Brady HR: Transcriptome profiling and the pathogenesis of diabetic complications. J Am Soc Nephrol 2003;14:S279-S283.
9. Gross O, Schulze-Lohoff E, Koepke ML, Beirowski B, Addicks K, Bloch W, Smyth N, Weber M: Antifibrotic, nephroprotective potential of ACE inhibitor vs. AT1 antagonist in a murine model of renal fibrosis. Nephrol Dial Transplant 2004;19:1716-1723.
10. Hilgers KF, Mann JF: Role of angiotensin II in glomerular injury: lessons from experimental and clinical studies. Kidney Blood Press Res 1996;19:254-262.
11. Okada K, Okawa E, Shibahara H, Maruyama T, Maruyama N, Matsumoto K, Takahashi S: Combination therapy with angiotensin-converting enzyme inhibitor and oral adsorbent of uremic toxins can delay the appearance of glomerular sclerosis and interstitial fibrosis in established renal failure. Kidney Blood Press Res 2004;27:218-225.
12. Prieto M, Rodriguez-Pena A, Arevalo M, Rivas JV, Duwel A, Eleno N, Sanchez RJ, Morales AI, Lopez-Novoa JM, Perez-Barriocanal F: Effect of the long-term treatment with trandolapril on endoglin expression in rats with experimental renal fibrosis induced by renal mass reduction. Kidney Blood Press Res 2005;28:32-40.
13. Wolf G: Vasoactive factors and tubulointerstitial injury. Kidney Blood Press Res 1999;22:62-70.
14. Bataller R, Brenner DA: Liver fibrosis. J Clin Invest 2005;115:209-218.
15. Kurikawa N, Suga M, Kuroda S, Yamada K, Ishikawa H: An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells. Br J Pharmacol 2003;139:1085-1094.
16. Nadrous HF, Ryu JH, Douglas WW, Decker PA, Olson EJ: Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis. Chest 2004;126:438-446.
17. Wilkinson-Berka JL, Fletcher EL: Angiotensin and bradykinin: targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy. Curr Pharm Des 2004;10:3313-3330.
18. Ahmed MS, Oie E, Vinge LE, Yndestad A, Oystein AG, Andersson Y, Attramadal T, Attramadal H: Connective tissue growth factor - a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats. J Mol Cell Cardiol 2004;36:393-404.
19. Andersen S, van Nieuwenhoven FA, Tarnow L, Rossing P, Rossing K, Wieten L, Goldschmeding R, Parving HH: Reduction of urinary connective tissue growth factor by losartan in type 1 patients with diabetic nephropathy. Kidney Int 2005;67:2325-2329.
20. Bolick DT, Hatley ME, Srinivasan S, Hedrick CC, Nadler JL: Lisofylline, a novel anti-inflammatory compound, protects mesangial cells from hyperglycemia- and angiotensin II-mediated extracellular matrix deposition. Endocrinology 2003;144:5227-5231.
21. Finckenberg P, Inkinen K, Ahonen J, Merasto S, Louhelainen M, Vapaatalo H, Muller D, Ganten D, Luft F, Mervaala E: Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. Am J Pathol 2003;163:355-366.
22. He Z, Way KJ, Arikawa E, Chou E, Opland DM, Clermont A, Isshiki K, Ma RC, Scott JA, Schoen FJ, Feener EP, King GL: Differential regulation of angiotensin II-induced expression of connective tissue growth factor by protein kinase C isoforms in the myocardium. J Biol Chem 2005;280:15719-15726.
23. Huang S, Liu F, Sha Z, Fu P, Yang Y, Xu Y, Zhou H: Effect of high glucose, angiotensin II and receptor antagonist losartan on the expression of connective tissue growth factor in cultured mesangial cells. Chin Med J (Engl) 2003;116:554-557.
24. Iwanciw D, Rehm M, Porst M, Goppelt-Struebe M: Induction of connective tissue growth factor by angiotensin II: integration of signaling pathways. Arterioscler Thromb Vasc Biol 2003;23:1782-1787.
25. Liu BC, Sun J, Chen Q, Ma KL, Ruan XZ, Phillips AO: Role of connective tissue growth factor in mediating hypertrophy of human proximal tubular cells induced by angiotensin II. Am J Nephrol 2003;23:429-437.
26. Ruperez M, Lorenzo O, Blanco-Colio LM, Esteban V, Egido J, Ruiz-Ortega M: Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Circulation 2003;108:1499-1505.
27. Ruperez M, Ruiz-Ortega M, Esteban V, Lorenzo O, Mezzano S, Plaza JJ, Egido J: Angiotensin II increases connective tissue growth factor in the kidney. Am J Pathol 2003;163:1937-1947.
28. Lee CI, Guh JY, Chen HC, Hung WC, Yang YL, Chuang LY: Advanced glycation end-product-induced mitogenesis and collagen production are dependent on angiotensin II and connective tissue growth factor in NRK-49F cells. J Cell Biochem 2005;95:281-292.
29. Lang F, Cohen P: Regulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoforms. Sci STKE 2001;2001:RE17.
30. Firestone GL, Giampaolo JR, O'Keeffe BA: Stimulus-dependent regulation of the serum-and glucocorticoid-inducible protein kinase (Sgk) transcription, subcellular localization and enzymatic activity. Cell Physiol Biochem 2003;13:1-12.
31. Lang F, Bohmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V: (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev 2006;86:1151-1178.
32. Simon P, Schneck M, Hochstetter T, Koutsouki E, Mittelbronn M, Merseburger A, Weigert C, Niess A, Lang F: Differential regulation of serum- and glucocorticoid-inducible kinase 1 (SGK1) splice variants based on alternative initiation of transcription. Cell Physiol Biochem 2007;20:715-728.
33. Pearce D: SGK1 regulation of epithelial sodium transport. Cell Physiol Biochem 2003;13:13-20.
34. + transport regulation in distal kidney nephron cells. Cell Physiol Biochem 2003;13:21-28.
35. Feng Y, Wang Q, Wang Y, Yard B, Lang F: SGK1-mediated fibronectin formation in diabetic nephropathy. Cell Physiol Biochem 2005;16:237-244.
36. Kumar JM, Brooks DP, Olson BA, Laping NJ: Sgk, a putative serine/threonine kinase, is differentially expressed in the kidney of diabetic mice and humans. J Am Soc Nephrol 1999;10:2488-2494.
37. Lang F, Klingel K, Wagner CA, Stegen C, Warntges S, Friedrich B, Lanzendorfer M, Melzig J, Moschen I, Steuer S, Waldegger S, Sauter M, Paulmichl M, Gerke V, Risler T, Gamba G, Capasso G, Kandolf R, Hebert SC, Massry SG, Broer S: Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci USA 2000;97:8157-8162.
38. Friedrich B, Warntges S, Klingel K, Sauter M, Kandolf R, Risler T, Muller GA, Witzgall R, Kriz W, Grone HJ, Lang F: Up-regulation of the human serum and glucocorticoid-dependent kinase-1 in glomerulonephritis. Kidney Blood Press Res 2002;25:303-307.
39. Vallon V, Wyatt AW, Klingel K, Huang DY, Hussain A, Berchtold S, Friedrich B, Grahammer F, Belaiba RS, Gorlach A, Wulff P, Daut J, Dalton ND, Ross J Jr, Flogel U, Schrader J, Osswald H, Kandolf R, Kuhl D, Lang F: SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment. J Mol Med 2006;84:396-404.
40. Wärntges S, Klingel K, Weigert C, Fillon S, Buck M, Schleicher E, Rodemann HP, Knabbe C, Kandolf R, Lang F: Excessive transcription of the human serum and glucocorticoid-dependent kinase hSGK1 in lung fibrosis. Cell Physiol Biochem 2002;12:135-142.
41. Fillon S, Klingel K, Warntges S, Sauter M, Gabrysch S, Pestel S, Tanneur V, Waldegger S, Zipfel A, Viebahn R, Haussinger D, Broer S, Kandolf R, Lang F: Expression of the serine/threonine kinase hSGK1 in chronic viral hepatitis. Cell Physiol Biochem 2002;12:47-54.
42. Waldegger S, Klingel K, Barth P, Sauter M, Rfer ML, Kandolf R, Lang F: h-sgk serine-threonine protein kinase gene as transcriptional target of transforming growth factor beta in human intestine. Gastroenterology 1999;116:1081-1088.
43. Klingel K, Warntges S, Bock J, Wagner CA, Sauter M, Waldegger S, Kandolf R, Lang F: Expression of cell volume-regulated kinase h-sgk in pancreatic tissue. Am J Physiol 2000;279:G998-G1002.
44. 1. Kidney Int 2003;63:878-888.
45. Schuttert JB, Liu MH, Gliem N, Fiedler GM, Zopf S, Mayer C, Muller GA, Grunewald RW: Human renal fibroblasts derived from normal and fibrotic kidneys show differences in increase of extracellular matrix synthesis and cell proliferation upon angiotensin II exposure. Pflügers Arch 2003;446:387-393.
46. + retention in the sgk1-knockout mouse. J Clin Invest 2002;110:1263-1268.
47. Moussad EE, Brigstock DR: Connective tissue growth factor: what's in a name? Mol Genet Metab 2000;71:276-292.
48. Brigstock DR: The CCN family: a new stimulus package. J Endocrinol 2003;178:169-175.
49. Ihn H: Pathogenesis of fibrosis: role of TGF-β and CTGF. Curr Opin Rheumatol 2002;14:681-685.
50. Perbal B: CCN proteins: multifunctional signalling regulators. Lancet 2004;363:62-64.
51. 2 in fibroblasts. J Biol Chem 2003;278:13008-13015.
52. Rachfal AW, Brigstock DR: Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res 2003;26:1-9.
53. Wang J, Barbry P, Maiyar AC, Rozansky DJ, Bhargava A, Leong M, Firestone GL, Pearce D: SGK integrates insulin and mineralocorticoid regulation of epithelial sodium transport. Am J Physiol Renal Physiol 2001;280:F303-F313.
54. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR: Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996;107:404-411.
55. Fujisawa G, Dilley R, Fullerton MJ, Funder JW: Experimental cardiac fibrosis: differential time course of responses to mineralocorticoid-salt administration. Endocrinology 2001;142:3625-3631.
56. Young M, Head G, Funder J: Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol 1995;269:E657-E662.
57. Brilla CG, Weber KT: Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. Cardiovasc Res 1992;26:671-677.
58. Young MJ, Funder JW: The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis. Am J Physiol 1996;271:E883-E888.
59. Zhang L, Cui R, Cheng X, Du J: Antiapoptotic effect of serum- and glucocorticoid-inducible protein kinase is mediated by novel mechanism activating IκB kinase. Cancer Res 2005;65:457-464.
60. Costanzo A, Moretti F, Burgio VL, Bravi C, Guido F, Levrero M, Puri PL: Endothelial activation by angiotensin II through NFκB and p38 pathways: involvement of NFκB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin. J Cell Physiol 2003;195:402-410.
61. Phillips MI, Kagiyama S: Angiotensin II as a pro-inflammatory mediator. Curr Opin Investig Drugs 2002;3:569-577.
62. Vaziri ND, Bai Y, Ni Z, Quiroz Y, Pandian R, Rodriguez-Iturbe B: Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction. J Pharmacol Exp Ther 2007;323:85-93.
63. Tharaux PL, Chatziantoniou C, Fakhouri F, Dussaule JC: Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway. Hypertension 2000;36:330-336.
64. Wyatt AW, Hussain A, Amann K, Klingel K, Kandolf R, Artunc F, Grahammer F, Huang DY, Vallon V, Kuhl D, Lang F: DOCA-induced phosphorylation of glycogen synthase kinase 3β. Cell Physiol Biochem 2006;17:137-144.
65. Hills CE, Bland R, Bennett J, Ronco PM, Squires PE: High glucose up-regulates ENaC and SGK1 expression in HCD-cells. Cell Physiol Biochem 2006;18:337-346.
66. Sato JD, Chapline MC, Thibodeau R, Frizzell RA, Stanton BA: Regulation of human cystic fibrosis transmembrane conductance regulator (CFTR) by serum- and glucocorticoid-inducible kinase (SGK1). Cell Physiol Biochem 2007;20:91-98.
67. Seebohm G, Strutz-Seebohm N, Baltaev R, Korniychuk G, Knirsch M, Engel J, Lang F: Regulation of KCNQ4 potassium channel prepulse dependence and current amplitude by SGK1 in Xenopus oocytes. Cell Physiol Biochem 2005;16:255-262.